Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Observed in pilot human work A 2025 IV infusion pilot of BPC-157 in two adults at 10 mg and 20 mg reported no adverse effects on cardiac, hepatic, renal, thyroid, or glucose biomarkers (Lee et al., Alternative Therapies in Health and Medicine, 2025)
J Pharmacol Exp Ther 2013;344:141-54
After 24 weeks, a mean weight loss of 6.6% in the treatment group and 0.3% in the placebo group are observed
(Fun fact: the P in GLP-1 stands for peptide.) Beyond these FDA-approved therapies is a much larger "gray market" of peptides
US$ 23.37
US$ 23.26
US$ 24.16
US$ 24.23
